company

Ludwig-Maximilians - University of Munich

as of 2026-07-01
Monitor thisAsk about this
at a glance
20 trials sponsored · 31 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

31 assets
AmisulprideCannabidiolClozapineOlanzapineRisperidoneAnti-inflammatory diet moduleClosed-loop transcranial alternating current stimulation (CL-tACS)Cognitive Behavioral Therapy (CBT)Exercise moduleFEEL GOODIBZM-SPECT (bolus and constant infusion paradigm)IPPI (Integrated Preventive Psychological Intervention)MagPro Cool-B65A/P, MagventureN-acetylcysteinePSM (Psychological stress management)Personalised medication advice based on pharmacogenetic testingPlacebPsychosocial interventionSemaglutide (SEMA)Sleep intervention moduleSocial prescribing moduleSocialVille Social Cognitive TrainingStructured lifestyle psychoeducationSupportive Counselling (SC)Supportive managementantipsychotics vs. Lorazepam (Drugs)balance and tone programeldith DC-stimulator (neuroconn, Ilmenau, Germany)endurance trainingmaintained antipsychotic treatment vs. stepwise drug discontinuationtranscranial direct current stimulation (tDCS)

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Amisulpride
small molecule
drug
Cannabidiol
small molecule
drug
Clozapine
small molecule
drug
Olanzapine
small molecule
drug
Risperidone
small molecule
drug
Anti-inflammatory diet module
BEHAVIORAL
drug
Closed-loop transcranial alternating current stimulation (CL-tACS)
DEVICE
drug
Cognitive Behavioral Therapy (CBT)
BEHAVIORAL
drug